Sprouty4 is an endogenous negative modulator of trka signaling and neuronal differentiation induced by ngf

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Alsina, Fernando C ^a   Irala, Dolores ^a   Fontanet, Paula A ^a   Hita, Francisco J ^a   Ledda, Fernanda ^a,b   Paratcha, Gustavo ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; RAC1 PROTEIN; REGULATOR PROTEIN; SPROUTY4 PROTEIN; TYROSINE; UNCLASSIFIED DRUG; NERVE PROTEIN; RAC1 PROTEIN, RAT; SMALL INTERFERING RNA; SPRY2 PROTEIN, RAT;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; GENE; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPRY4 GENE; WILD TYPE; ANIMAL; CELL STRAIN; CELL STRAIN COS1; CHEMISTRY; METABOLISM; METHODOLOGY; MUTATION; NERVE CELL; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COS CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MAP KINASE SIGNALING SYSTEM; MUTATION; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NEURONS; PC12 CELLS; RAC1 GTP-BINDING PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, TRKA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84857601893     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032087     Document Type: Article

References (39)

1. Segal RA, (2003) Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 26: 299-330.
2. Huang EJ, Reichardt LF, (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72: 609-642.
3. Dikic I, Giordano S, (2003) Negative receptor signalling. Curr Opin Cell Biol 15: 128-135.
4. Ledda F, Paratcha G, (2007) Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field. Biomark Insights 2: 45-58.
5. Mason JM, Morrison DJ, Basson MA, Licht JD, (2006) Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16: 45-54.
6. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA, (1998) sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92: 253-263.
7. Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, et al. (2001) Mammalian sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 152: 1087-1098.
8. Gross I, Armant O, Benosman S, de Aguilar JL, Freund JN, et al. (2007) Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ 14: 1802-1812.
9. Ishida M, Ichihara M, Mii S, Jijiwa M, Asai N, et al. (2007) Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase. Cancer Sci 98: 815-821.
10. Gross I, Bassit B, Benezra M, Licht JD, (2001) Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 276: 46460-46468.
11. Ayada T, Taniguchi K, Okamoto F, Kato R, Komune S, et al. (2009) Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis. Oncogene 28: 1076-1088.
12. Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A, (2001) Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem 276: 36804-36808.
13. Wong ES, Lim J, Low BC, Chen Q, Guy GR, (2001) Evidence for direct interaction between Sprouty and Cbl. J Biol Chem 276: 5866-5875.
14. Egan JE, Hall AB, Yatsula BA, Bar-Sagi D, (2002) The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc Natl Acad Sci U S A 99: 6041-6046.
15. Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, et al. (2003) Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr Biol 13: 297-307.
16. Vetter IR, Wittinghofer A, (2001) The guanine nucleotide-binding switch in three dimensions. Science 294: 1299-1304.
17. Nusser N, Gosmanova E, Zheng Y, Tigyi G, (2002) Nerve growth factor signals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 cells. J Biol Chem 277: 35840-35846.
18. Fard SS, Kele J, Vilar M, Paratcha G, Ledda F, (2010) Tiam1 as a signaling mediator of nerve growth factor-dependent neurite outgrowth. PLoS One 5: e9647.
19. Poppleton HM, Edwin F, Jaggar L, Ray R, Johnson LR, et al. (2004) Sprouty regulates cell migration by inhibiting the activation of Rac1 GTPase. Biochem Biophys Res Commun 323: 98-103.
20. Mason JM, Morrison DJ, Bassit B, Dimri M, Band H, et al. (2004) Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop. Mol Biol Cell 15: 2176-2188.
21. Lao DH, Chandramouli S, Yusoff P, Fong CW, Saw TY, et al. (2006) A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem 281: 29993-30000.
22. Ernsberger U, (2009) Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia. Cell Tissue Res 336: 349-384.
23. Panagiotaki N, Dajas-Bailador F, Amaya E, Papalopulu N, Dorey K, (2010) Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo. Development 137: 4005-4015.
24. Li X, Wheldon L, Heath JK, (2003) Sprouty: a controversial role in receptor tyrosine kinase signalling pathways. Biochem Soc Trans 31: 1445-1446.
25. Lee SH, Schloss DJ, Jarvis L, Krasnow MA, Swain JL, (2001) Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem 276: 4128-4133.
26. Hanafusa H, Torii S, Yasunaga T, Nishida E, (2002) Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4: 850-858.
27. Leeksma OC, Van Achterberg TA, Tsumura Y, Toshima J, Eldering E, et al. (2002) Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. Eur J Biochem 269: 2546-2556.
28. Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, et al. (2002) Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 277: 3195-3201.
29. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, et al. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 5: 427-432.
30. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, et al. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Cell Cycle 2: 281-282.
31. Reichardt LF, (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545-1564.
32. Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y, (1999) Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126: 2515-2525.
33. Akbulut S, Reddi AL, Aggarwal P, Ambardekar C, Canciani B, et al. (2010) Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C. Mol Biol Cell 21: 3487-3496.
34. Tsumura Y, Toshima J, Leeksma OC, Ohashi K, Mizuno K, (2005) Sprouty-4 negatively regulates cell spreading by inhibiting the kinase activity of testicular protein kinase. Biochem J 387: 627-637.
35. Sofroniew MV, Howe CL, Mobley WC, (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24: 1217-1281.
36. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, et al. (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39: 1120-1126.
37. Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim HP, et al. (2009) SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 46: 431-437.
38. Ledda F, Bieraugel O, Fard SS, Vilar M, Paratcha G, (2008) Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J Neurosci 28: 39-49.
39. Baudet C, Mikaels A, Westphal H, Johansen J, Johansen TE, et al. (2000) Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins. Development 127: 4335-4344.